Jubilant Ingrevia has commissioned new Diketene derivatives facility at its manufacturing site in North India at Gajraula, Uttar Pradesh. The company for many years has niche expertise in using Ketene chemistry technology. Using the Ketene chemistry capability, the company has developed a range of Diketene Derivatives. The newly commissioned facility marks the entry of the company into the fast growing Diketene business portfolio. This reiterates Jubilant Ingrevia’a commitment towards growth through its integrated business model, by providing value added products & innovative solutions to its customers.
The commissioned facility has about 7,000 TPA capacity to produce various Esters (Mono Methyl Acetoacetamide, Methyl Acetoacetate, Ethyl Acetoacetate and Ter-Butyl Acetoacetate). The Company’s long-standing association with leading customers in Pharmaceuticals, Agrochemicals and other industries and its advance efforts to get product approval from customers, will help in utilizing a major portion of the capacity of this new facility in the coming months. Jubilant Ingrevia undertakes to commission future phases of Diketene Derivatives as per plan.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
